Prothena | PRTA - Current Liabilities

Stock Price
9.10
Daily Change
-0.11 -1.19%
Monthly
1.56%
Yearly
-33.77%
Q1 Forecast
8.93

Prothena reported $51.44M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 277.11M 79.47M Dec/2025
Agios Pharmaceuticals USD 82.21M 7.45M Dec/2025
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
ALKERMES USD 543.44M 69.08M Dec/2025
Alnylam Pharmaceuticals USD 1.47B 89.13M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Immunic USD 30.08M 2.77M Sep/2025
Incyte USD 1.52B 176.44M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Neurocrine Biosciences USD 743.4M 105.4M Dec/2025
Prothena USD 51.44M 16.37M Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Ultragenyx Pharmaceutical USD 340.02M 46.78M Sep/2025
Vertex Pharmaceuticals USD 3.86B 614.1M Dec/2025
Xoma USD 28.3M 6.81M Sep/2025